These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23312048)

  • 21. Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection.
    Meyers CD; Kashyap ML
    Curr Opin Cardiol; 2004 Jul; 19(4):366-73. PubMed ID: 15218398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.
    Sorci-Thomas MG; Thomas MJ
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2561-5. PubMed ID: 23077142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
    Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.
    Shao B; Oda MN; Vaisar T; Oram JF; Heinecke JW
    Curr Opin Mol Ther; 2006 Jun; 8(3):198-205. PubMed ID: 16774039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rate-limiting factors of cholesterol efflux in reverse cholesterol transport: acceptors and donors.
    Fu Y
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):703-9. PubMed ID: 20374257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel therapies to increase apolipoprotein AI and HDL for the treatment of atherosclerosis.
    Wong NC
    Curr Opin Investig Drugs; 2007 Sep; 8(9):718-28. PubMed ID: 17729183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
    Daniil G; Phedonos AA; Holleboom AG; Motazacker MM; Argyri L; Kuivenhoven JA; Chroni A
    Clin Chim Acta; 2011 Jun; 412(13-14):1213-20. PubMed ID: 21420943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
    Maïga SF; Kalopissis AD; Chabert M
    Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection.
    Escolà-Gil JC; Rotllan N; Julve J; Blanco-Vaca F
    Atherosclerosis; 2009 Oct; 206(2):321-7. PubMed ID: 19362310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Highlights of ATVB.
    Dron JS; Lazarte J; Hegele RA
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):e185-e197. PubMed ID: 30354244
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiinflammatory actions of HDL: a new insight.
    Rye KA; Barter PJ
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1890-1. PubMed ID: 18946054
    [No Abstract]   [Full Text] [Related]  

  • 32. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
    Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D
    Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease.
    Brewer HB; Remaley AT; Neufeld EB; Basso F; Joyce C
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1755-60. PubMed ID: 15319263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.
    Charles-Schoeman C; Lee YY; Grijalva V; Amjadi S; FitzGerald J; Ranganath VK; Taylor M; McMahon M; Paulus HE; Reddy ST
    Ann Rheum Dis; 2012 Jul; 71(7):1157-62. PubMed ID: 22267330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 fatty acids and HDL. How do they work in the prevention of cardiovascular disease?
    Burillo E; Martín-Fuentes P; Mateo-Gallego R; Baila-Rueda L; Cenarro A; Ros E; Civeira F
    Curr Vasc Pharmacol; 2012 Jul; 10(4):432-41. PubMed ID: 22339302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver.
    Matsuura F; Oku H; Koseki M; Sandoval JC; Yuasa-Kawase M; Tsubakio-Yamamoto K; Masuda D; Maeda N; Tsujii K; Ishigami M; Nishida M; Hirano K; Kihara S; Hori M; Shimomura I; Yamashita S
    Biochem Biophys Res Commun; 2007 Jul; 358(4):1091-5. PubMed ID: 17521614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia.
    Inagaki M; Nakagawa-Toyama Y; Nishida M; Nakatani K; Nakaoka H; Kawase M; Kawase R; Tsubakio-Yamamoto K; Masuda D; Ohama T; Matsuyama A; Ishigami M; Komuro I; Yamashita S
    J Atheroscler Thromb; 2012; 19(7):643-56. PubMed ID: 22785024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
    Tuteja S; Rader DJ
    Clin Pharmacol Ther; 2014 Jul; 96(1):48-56. PubMed ID: 24713591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity.
    Huang J; Yancey PG; Tao H; Borja MS; Smith LE; Kon V; Davies SS; Linton MF
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32629758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular regulation of macrophage reverse cholesterol transport.
    Wang X; Rader DJ
    Curr Opin Cardiol; 2007 Jul; 22(4):368-72. PubMed ID: 17556891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.